These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 17630789)

  • 1. Targeted quantum dot conjugates for siRNA delivery.
    Derfus AM; Chen AA; Min DH; Ruoslahti E; Bhatia SN
    Bioconjug Chem; 2007; 18(5):1391-6. PubMed ID: 17630789
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional quantum-dot-based siRNA delivery for HPV18 E6 gene silence and intracellular imaging.
    Li JM; Zhao MX; Su H; Wang YY; Tan CP; Ji LN; Mao ZW
    Biomaterials; 2011 Nov; 32(31):7978-87. PubMed ID: 21784514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of poly(amino ester glycol urethane)/siRNA polyplexes for gene silencing.
    Tseng SJ; Tang SC
    Bioconjug Chem; 2007; 18(5):1383-90. PubMed ID: 17567100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference.
    Tan WB; Jiang S; Zhang Y
    Biomaterials; 2007 Mar; 28(8):1565-71. PubMed ID: 17161865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A pH-sensitive fusogenic peptide facilitates endosomal escape and greatly enhances the gene silencing of siRNA-containing nanoparticles in vitro and in vivo.
    Hatakeyama H; Ito E; Akita H; Oishi M; Nagasaki Y; Futaki S; Harashima H
    J Control Release; 2009 Oct; 139(2):127-32. PubMed ID: 19540888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular siRNA delivery system using polyelectrolyte complex micelles prepared from VEGF siRNA-PEG conjugate and cationic fusogenic peptide.
    Lee SH; Kim SH; Park TG
    Biochem Biophys Res Commun; 2007 Jun; 357(2):511-6. PubMed ID: 17434451
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biodegradable amphiphilic poly(ethylene oxide)-block-polyesters with grafted polyamines as supramolecular nanocarriers for efficient siRNA delivery.
    Xiong XB; Uludağ H; Lavasanifar A
    Biomaterials; 2009 Jan; 30(2):242-53. PubMed ID: 18838158
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A peptide-targeted delivery system with pH-sensitive amphiphilic cell membrane disruption for efficient receptor-mediated siRNA delivery.
    Wang XL; Xu R; Lu ZR
    J Control Release; 2009 Mar; 134(3):207-13. PubMed ID: 19135104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted cellular uptake and siRNA silencing by quantum-dot nanoparticles coated with β-cyclodextrin coupled to amino acids.
    Zhao MX; Li JM; Du L; Tan CP; Xia Q; Mao ZW; Ji LN
    Chemistry; 2011 Apr; 17(18):5171-9. PubMed ID: 21465588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gene silencing efficiency of siRNA-PEG conjugates: effect of PEGylation site and PEG molecular weight.
    Jung S; Lee SH; Mok H; Chung HJ; Park TG
    J Control Release; 2010 Jun; 144(3):306-13. PubMed ID: 20206653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeted delivery of siRNA by nonviral vectors: lessons learned from recent advances.
    Li SD; Huang L
    Curr Opin Investig Drugs; 2008 Dec; 9(12):1317-23. PubMed ID: 19037838
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficient delivery of Bcl-2-targeted siRNA using cationic polymer nanoparticles: downregulating mRNA expression level and sensitizing cancer cells to anticancer drug.
    Beh CW; Seow WY; Wang Y; Zhang Y; Ong ZY; Ee PL; Yang YY
    Biomacromolecules; 2009 Jan; 10(1):41-8. PubMed ID: 19072631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Receptor-targeted liposome-peptide nanocomplexes for siRNA delivery.
    Tagalakis AD; He L; Saraiva L; Gustafsson KT; Hart SL
    Biomaterials; 2011 Sep; 32(26):6302-15. PubMed ID: 21624650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantum dot-carrier peptide conjugates suitable for imaging and delivery applications.
    Walther C; Meyer K; Rennert R; Neundorf I
    Bioconjug Chem; 2008 Dec; 19(12):2346-56. PubMed ID: 18991369
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intracellular trafficking and unpacking of siRNA/quantum dot-PEI complexes modified with and without cell penetrating peptide: confocal and flow cytometric FRET analysis.
    Lee H; Kim IK; Park TG
    Bioconjug Chem; 2010 Feb; 21(2):289-95. PubMed ID: 20078095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in the development of siRNA-based therapeutics for cancer.
    Shen Y
    IDrugs; 2008 Aug; 11(8):572-8. PubMed ID: 18683092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A nanoparticle system specifically designed to deliver short interfering RNA inhibits tumor growth in vivo.
    Yagi N; Manabe I; Tottori T; Ishihara A; Ogata F; Kim JH; Nishimura S; Fujiu K; Oishi Y; Itaka K; Kato Y; Yamauchi M; Nagai R
    Cancer Res; 2009 Aug; 69(16):6531-8. PubMed ID: 19654315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. siRNA-mediated antitumorigenesis for drug target validation and therapeutics.
    Lu PY; Xie FY; Woodle MC
    Curr Opin Mol Ther; 2003 Jun; 5(3):225-34. PubMed ID: 12870431
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward a siRNA-containing nanoparticle targeted to breast cancer cells and the tumor microenvironment.
    Gomes-da-Silva LC; Santos AO; Bimbo LM; Moura V; Ramalho JS; Pedroso de Lima MC; Simões S; Moreira JN
    Int J Pharm; 2012 Sep; 434(1-2):9-19. PubMed ID: 22617794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multifunctional nanogels for siRNA delivery.
    Smith MH; Lyon LA
    Acc Chem Res; 2012 Jul; 45(7):985-93. PubMed ID: 22181582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.